Actinium Pharmaceuticals's total assets for Q2 2025 were $63.02M, a decrease of -8.20% from the previous quarter. ATNM total liabilities were $44.00M for the fiscal quarter, a 2.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.